Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Dygtig sygepleje i hjemmet

3. november 2026 opdateret af: David Levine, Brigham and Women's Hospital

Dygtig sygepleje i hjemmet: Et randomiseret kontrolleret forsøg

We will perform a parallel-group multicenter patient-level randomized controlled evaluation of skilled nursing facility care at home. Patients typically referred to a skilled nursing facility following hospitalization will be eligible for enrollment. Instead of admission to a skilled nursing facility, participants will receive care from a technology-enabled team in their own homes or will be allocated to receive care in a traditional skilled nursing facility setting.

Studieoversigt

Status

Afsluttet

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

244

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Massachusetts
      • Boston, Massachusetts, Forenede Stater, 02114
        • Massachusetts General Hospital
      • Boston, Massachusetts, Forenede Stater, 02118
        • Boston Medical Center
      • Boston, Massachusetts, Forenede Stater, 02120
        • Brigham and Women's Hospital
      • Boston, Massachusetts, Forenede Stater, 02130
        • Brigham and Women's Faulkner Hospital
      • Cambridge, Massachusetts, Forenede Stater, 02139
        • Cambridge Health Alliance

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • >=18 years old
  • Requires SNF PAC care following hospitalization, as determined by the inpatient team (requires documented rehabilitative therapy recommendation)
  • Community-dwelling before hospitalization
  • Likely to return to community-dwelling status following short-term rehabilitation as determined by RAH liaison
  • Lives within 10 miles of any study site hospital (or per specified catchment)
  • Surgical trauma and elective patients (weight bearing as tolerated and transfer with no more than one-person assist)
  • Neurology patients - Stroke (needs acute rehabilitation, but insurance will not cover, so bound for SNF. Does not meet acute rehabilitation criteria and does not need long-term placement)

Exclusion Criteria:

  • Environmental

    • Undomiciled
    • No working heat (October-April), no working air conditioning if forecast > 80°F, or no running water
    • In police custody
    • Resides in a facility that does not allow advanced on-site care
    • Domestic violence screen positive
    • Weapons that cannot be appropriately secured
    • Difficulty accessing the bathroom (unless there is space for a bedside commode where the patient sleeps or if the patient is entirely dependent on toileting)
    • Home has insufficient accessible space to sleep, eat, and perform rehabilitative therapy
    • Home lacks sufficient kitchen facilities to either cook or heat meals
    • Patient, or patient's family caregiver, unable to communicate via telephone
    • Patient, or patient's family caregiver, lacks consistent access to a telephone
  • Clinical

    • Requires more than one assist (unless the family can provide additional 24/7 assistance)
    • Requires care of new ostomy or teaching ostomy care
    • Requires frequent suctioning, tracheostomy, and ventilator needs
    • Requires total parenteral nutrition
    • Requires nasogastric tube feeds
    • Requires durable medical equipment not already in place at home and excluded below
    • Requires daily subcutaneous injection unless patient or family caregiver is teachable and able to administer daily
    • Acute delirium noted by RAH liaison requiring more than one caregiver
    • Active psychiatric diagnosis without an adequate treatment plan
    • On methadone requiring daily pickup of medication
    • Requires administration of intravenous controlled substances
    • Requires administration of specialty medications not already in place at home
    • Requires transfusion of blood products
    • Requires three times weekly or more transfers back and forth to obtain specialty medical care
    • Requires hemodialysis
    • Orthopedic trauma and elective patients
    • Traumatic brain injury
    • Wound or appliance care that requires daily nursing care
    • For spine trauma: neurologic deficits requiring more than one assist
  • Neurology patients

    • PRESS score (for ischemic stroke; use PRESS app): no return to pre-stroke diet > 50%
    • FUNC score (for primary intracerebral hemorrhage only): <75% probability of functional independence at 90 days
    • ASTRAL score (for ischemic stroke only and patients with pre-stroke independence [Modified Rankin Scale 0-2]): <75% probability of a 90-day poor functional outcome (Modified Rankin Scale result of 3-6)
  • RAH census is full

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Andet
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Ingen indgriben: Usual skilled nursing facility care

Control subjects will receive care at a skilled nursing facility as per usual.

Aktiv komparator: Rehab at home

Intervention subjects will receive care in their home from a specialized care team.

Skilled nursing facility care at home delivers a range of advanced rehabilitation services in patients' homes, enabling care at home despite requiring intensive rehabilitative care. Our approach blends personalized, high-level professional care with innovative technology applications to ensure adequate rehabilitation.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in activities of daily living between admission to rehab and discharge from rehab
Tidsramme: Admission to rehab until discharge from rehab, no more than 6 months

Subtract the patient's activities of daily living at discharge from rehab from the patient's activities of daily living on admission to rehab.

Admission to rehab until discharge from rehab, no more than 6 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Percent time supine per day
Tidsramme: Admission to rehab until discharge from rehab, no more than 6 months

The percentage of time a patient is supine per day, as measured by their wrist-worn accelerometer.

Admission to rehab until discharge from rehab, no more than 6 months
Total direct medical expenditure
Tidsramme: Admission to rehab until discharge from rehab, no more than 6 months

The percent difference in direct cost of care to deliver rehab care.

Admission to rehab until discharge from rehab, no more than 6 months
Patient experience with care
Tidsramme: Admission to rehab until discharge from rehab, no more than 6 months

The Picker patient experience questionaire-15

Admission to rehab until discharge from rehab, no more than 6 months
30-day readmission or 30-day mortality
Tidsramme: Discharge from rehab until 30-days later, no more than 30-days

The percentage of patients who are readmitted or deceased within 30-days of discharge from rehab.

Discharge from rehab until 30-days later, no more than 30-days

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

3. juni 2024

Primær færdiggørelse (Faktiske)

22. oktober 2025

Studieafslutning (Faktiske)

2. april 2026

Datoer for studieregistrering

Først indsendt

11. maj 2024

Først indsendt, der opfyldte QC-kriterier

11. maj 2024

Først opslået (Faktiske)

16. maj 2024

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

5. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

3. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 2024P000266

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner